Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 110

1.

Are working practices of lung cancer nurse specialists associated with variation in peoples' receipt of anticancer therapy?

Stewart I, Khakwani A, Hubbard RB, Beckett P, Borthwick D, Tod A, Leary A, Tata LJ.

Lung Cancer. 2018 Sep;123:160-165. doi: 10.1016/j.lungcan.2018.07.022. Epub 2018 Jul 17.

2.

Novel insights into the aetiology of granulomatosis with polyangiitis-a case-control study using the Clinical Practice Research Datalink.

Pearce FA, Lanyon PC, Watts RA, Grainge MJ, Abhishek A, Hubbard RB.

Rheumatology (Oxford). 2018 Jul 27. doi: 10.1093/rheumatology/key249. [Epub ahead of print] No abstract available.

PMID:
30060158
3.

Novel insights into the aetiology of granulomatosis with polyangiitis-a case-control study using the Clinical Practice Research Datalink.

Pearce FA, Lanyon PC, Watts RA, Grainge MJ, Abhishek A, Hubbard RB.

Rheumatology (Oxford). 2018 Jun 1;57(6):1002-1010. doi: 10.1093/rheumatology/kex512.

4.

Can granulomatosis with polyangiitis be diagnosed earlier in primary care? A case-control study.

Pearce FA, Hubbard RB, Grainge MJ, Watts RA, Abhishek A, Lanyon PC.

QJM. 2018 Jan 1;111(1):39-45. doi: 10.1093/qjmed/hcx194.

PMID:
29340693
5.

Cardiovascular Outcomes after a Respiratory Tract Infection among Adults with Non-Cystic Fibrosis Bronchiectasis: A General Population-based Study.

Navaratnam V, Root AA, Douglas I, Smeeth L, Hubbard RB, Quint JK.

Ann Am Thorac Soc. 2018 Mar;15(3):315-321. doi: 10.1513/AnnalsATS.201706-488OC.

PMID:
29266966
6.

Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study.

Allen RJ, Porte J, Braybrooke R, Flores C, Fingerlin TE, Oldham JM, Guillen-Guio B, Ma SF, Okamoto T, John AE, Obeidat M, Yang IV, Henry A, Hubbard RB, Navaratnam V, Saini G, Thompson N, Booth HL, Hart SP, Hill MR, Hirani N, Maher TM, McAnulty RJ, Millar AB, Molyneaux PL, Parfrey H, Rassl DM, Whyte MKB, Fahy WA, Marshall RP, Oballa E, Bossé Y, Nickle DC, Sin DD, Timens W, Shrine N, Sayers I, Hall IP, Noth I, Schwartz DA, Tobin MD, Wain LV, Jenkins RG.

Lancet Respir Med. 2017 Nov;5(11):869-880. doi: 10.1016/S2213-2600(17)30387-9. Epub 2017 Oct 20.

7.

Extracellular Matrix Cross-Linking Enhances Fibroblast Growth and Protects against Matrix Proteolysis in Lung Fibrosis.

Philp CJ, Siebeke I, Clements D, Miller S, Habgood A, John AE, Navaratnam V, Hubbard RB, Jenkins G, Johnson SR.

Am J Respir Cell Mol Biol. 2018 May;58(5):594-603. doi: 10.1165/rcmb.2016-0379OC.

PMID:
29053339
8.

Timing of onset of symptoms in people with idiopathic pulmonary fibrosis.

Hewson T, McKeever TM, Gibson JE, Navaratnam V, Hubbard RB, Hutchinson JP.

Thorax. 2017 Oct 11. pii: thoraxjnl-2017-210177. doi: 10.1136/thoraxjnl-2017-210177. [Epub ahead of print]

PMID:
29021387
9.

Apples and pears? A comparison of two sources of national lung cancer audit data in England.

Khakwani A, Jack RH, Vernon S, Dickinson R, Wood N, Harden S, Beckett P, Woolhouse I, Hubbard RB.

ERJ Open Res. 2017 Jul 21;3(3). pii: 00003-2017. doi: 10.1183/23120541.00003-2017. eCollection 2017 Jul.

10.

The incidence, prevalence and mortality of granulomatosis with polyangiitis in the UK Clinical Practice Research Datalink.

Pearce FA, Grainge MJ, Lanyon PC, Watts RA, Hubbard RB.

Rheumatology (Oxford). 2017 Apr 1;56(4):589-596. doi: 10.1093/rheumatology/kew413.

PMID:
28013209
11.

Reply: Surgical Lung Biopsy: The Role of Better Surgery.

Hutchinson JP, Fogarty AW, McKeever TM, Hubbard RB.

Am J Respir Crit Care Med. 2016 Nov 15;194(10):1303. No abstract available.

PMID:
27845587
12.

Risk of venous thromboembolism in people with lung cancer: a cohort study using linked UK healthcare data.

Walker AJ, Baldwin DR, Card TR, Powell HA, Hubbard RB, Grainge MJ.

Br J Cancer. 2017 Mar 14;116(6):e1. doi: 10.1038/bjc.2016.364. Epub 2016 Nov 1. No abstract available.

13.

Surgical lung biopsy for the diagnosis of interstitial lung disease in England: 1997-2008.

Hutchinson JP, McKeever TM, Fogarty AW, Navaratnam V, Hubbard RB.

Eur Respir J. 2016 Nov;48(5):1453-1461. doi: 10.1183/13993003.00378-2016. Epub 2016 Sep 22.

14.

Bronchiectasis and the risk of cardiovascular disease: a population-based study.

Navaratnam V, Millett ER, Hurst JR, Thomas SL, Smeeth L, Hubbard RB, Brown J, Quint JK.

Thorax. 2017 Feb;72(2):161-166. doi: 10.1136/thoraxjnl-2015-208188. Epub 2016 Aug 29.

15.

Place of Death in Patients with Lung Cancer: A Retrospective Cohort Study from 2004-2013.

O'Dowd EL, McKeever TM, Baldwin DR, Hubbard RB.

PLoS One. 2016 Aug 23;11(8):e0161399. doi: 10.1371/journal.pone.0161399. eCollection 2016.

16.

Incidence of ANCA-associated vasculitis in a UK mixed ethnicity population.

Pearce FA, Lanyon PC, Grainge MJ, Shaunak R, Mahr A, Hubbard RB, Watts RA.

Rheumatology (Oxford). 2016 Sep;55(9):1656-63. doi: 10.1093/rheumatology/kew232. Epub 2016 Jun 5.

PMID:
27274096
17.

Risk of venous thromboembolism in people with lung cancer: a cohort study using linked UK healthcare data.

Walker AJ, Baldwin DR, Card TR, Powell HA, Hubbard RB, Grainge MJ.

Br J Cancer. 2016 Jun 28;115(1):115-21. doi: 10.1038/bjc.2016.143. Epub 2016 Jun 2.

18.

Which patients are assessed by lung cancer nurse specialists? A national lung cancer audit study of over 128,000 patients across england.

Khakwani A, Hubbard RB, Beckett P, Borthwick D, Tod A, Leary A, White J, Tata LJ.

Lung Cancer. 2016 Jun;96:33-40. doi: 10.1016/j.lungcan.2016.03.011. Epub 2016 Mar 26.

19.

Predicting death from surgery for lung cancer: A comparison of two scoring systems in two European countries.

O'Dowd EL, Lüchtenborg M, Baldwin DR, McKeever TM, Powell HA, Møller H, Jakobsen E, Hubbard RB.

Lung Cancer. 2016 May;95:88-93. doi: 10.1016/j.lungcan.2016.03.002. Epub 2016 Mar 15.

PMID:
27040857
20.

Refining adverse drug reaction signals by incorporating interaction variables identified using emergent pattern mining.

Reps JM, Aickelin U, Hubbard RB.

Comput Biol Med. 2016 Feb 1;69:61-70. doi: 10.1016/j.compbiomed.2015.11.014. Epub 2015 Dec 4.

PMID:
26722822
21.

In-Hospital Mortality after Surgical Lung Biopsy for Interstitial Lung Disease in the United States. 2000 to 2011.

Hutchinson JP, Fogarty AW, McKeever TM, Hubbard RB.

Am J Respir Crit Care Med. 2016 May 15;193(10):1161-7. doi: 10.1164/rccm.201508-1632OC.

PMID:
26646481
22.

Critical care admission trends and outcomes in individuals with bronchiectasis in the UK.

Navaratnam V, Muirhead CR, Hubbard RB, De Soyza A.

QJM. 2016 Aug;109(8):523-6. doi: 10.1093/qjmed/hcv206. Epub 2015 Nov 17.

23.

Patients' attitudes to risk in lung cancer surgery: A qualitative study.

Powell HA, Jones LL, Baldwin DR, Duffy JP, Hubbard RB, Tod AM, Tata LJ, Solomon J, Bains M.

Lung Cancer. 2015 Nov;90(2):358-63. doi: 10.1016/j.lungcan.2015.08.014. Epub 2015 Aug 24.

24.

Congenital Anomalies in Children of Mothers Taking Antiepileptic Drugs with and without Periconceptional High Dose Folic Acid Use: A Population-Based Cohort Study.

Ban L, Fleming KM, Doyle P, Smeeth L, Hubbard RB, Fiaschi L, Tata LJ.

PLoS One. 2015 Jul 6;10(7):e0131130. doi: 10.1371/journal.pone.0131130. eCollection 2015.

25.

A supervised adverse drug reaction signalling framework imitating Bradford Hill's causality considerations.

Reps JM, Garibaldi JM, Aickelin U, Gibson JE, Hubbard RB.

J Biomed Inform. 2015 Aug;56:356-68. doi: 10.1016/j.jbi.2015.06.011. Epub 2015 Jun 24.

26.

Complications and mortality in hereditary hemorrhagic telangiectasia: A population-based study.

Donaldson JW, McKeever TM, Hall IP, Hubbard RB, Fogarty AW.

Neurology. 2015 May 5;84(18):1886-93. doi: 10.1212/WNL.0000000000001538. Epub 2015 Apr 10.

27.

Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study.

Jenkins RG, Simpson JK, Saini G, Bentley JH, Russell AM, Braybrooke R, Molyneaux PL, McKeever TM, Wells AU, Flynn A, Hubbard RB, Leeming DJ, Marshall RP, Karsdal MA, Lukey PT, Maher TM.

Lancet Respir Med. 2015 Jun;3(6):462-72. doi: 10.1016/S2213-2600(15)00048-X. Epub 2015 Mar 12.

28.

Non-small cell lung cancer in young adults: presentation and survival in the English National Lung Cancer Audit.

Rich AL, Khakwani A, Free CM, Tata LJ, Stanley RA, Peake MD, Hubbard RB, Baldwin DR.

QJM. 2015 Nov;108(11):891-7. doi: 10.1093/qjmed/hcv052. Epub 2015 Feb 26.

PMID:
25725079
29.

Author's response: What characteristics of primary care and patients are associated with early death in patients with lung cancer in the UK?

O'Dowd EL, McKeever TM, Baldwin DR, Anwar S, Powell HA, Gibson JE, Iyen-Omofoman B, Hubbard RB.

Thorax. 2015 Feb;70(2):185. doi: 10.1136/thoraxjnl-2014-206638. No abstract available.

30.

Venous thromboembolism in people with idiopathic pulmonary fibrosis: a population-based study.

Dalleywater W, Powell HA, Fogarty AW, Hubbard RB, Navaratnam V.

Eur Respir J. 2014 Dec;44(6):1714-5. doi: 10.1183/09031936.00099614. Epub 2014 Oct 16. No abstract available.

31.

What characteristics of primary care and patients are associated with early death in patients with lung cancer in the UK?

O'Dowd EL, McKeever TM, Baldwin DR, Anwar S, Powell HA, Gibson JE, Iyen-Omofoman B, Hubbard RB.

Thorax. 2015 Feb;70(2):161-8. doi: 10.1136/thoraxjnl-2014-205692. Epub 2014 Oct 13.

32.

Natural history of angiomyolipoma in lymphangioleiomyomatosis: implications for screening and surveillance.

Yeoh ZW, Navaratnam V, Bhatt R, McCafferty I, Hubbard RB, Johnson SR.

Orphanet J Rare Dis. 2014 Oct 3;9:151. doi: 10.1186/s13023-014-0151-3.

33.

The impact of the 'hub and spoke' model of care for lung cancer and equitable access to surgery.

Khakwani A, Rich AL, Powell HA, Tata LJ, Stanley RA, Baldwin DR, Duffy JP, Hubbard RB.

Thorax. 2015 Feb;70(2):146-51. doi: 10.1136/thoraxjnl-2014-205841. Epub 2014 Sep 2.

PMID:
25182047
34.

Increasing global mortality from idiopathic pulmonary fibrosis in the twenty-first century.

Hutchinson JP, McKeever TM, Fogarty AW, Navaratnam V, Hubbard RB.

Ann Am Thorac Soc. 2014 Oct;11(8):1176-85. doi: 10.1513/AnnalsATS.201404-145OC.

PMID:
25165873
35.

Risk factors for cardiovascular disease in people with idiopathic pulmonary fibrosis: a population-based study.

Dalleywater W, Powell HA, Hubbard RB, Navaratnam V.

Chest. 2015 Jan;147(1):150-156. doi: 10.1378/chest.14-0041.

PMID:
25121965
36.

Comorbidities in rotator cuff disease: a case-control study.

Titchener AG, White JJ, Hinchliffe SR, Tambe AA, Hubbard RB, Clark DI.

J Shoulder Elbow Surg. 2014 Sep;23(9):1282-8. doi: 10.1016/j.jse.2013.12.019. Epub 2014 Mar 4.

PMID:
24618192
37.

Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study.

Ban L, Gibson JE, West J, Fiaschi L, Sokal R, Smeeth L, Doyle P, Hubbard RB, Tata LJ.

BJOG. 2014 Nov;121(12):1471-81. doi: 10.1111/1471-0528.12682. Epub 2014 Mar 11.

38.

An epidemiological study of rotator cuff pathology using The Health Improvement Network database.

White JJ, Titchener AG, Fakis A, Tambe AA, Hubbard RB, Clark DI.

Bone Joint J. 2014 Mar;96-B(3):350-3. doi: 10.1302/0301-620X.96B3.32336.

PMID:
24589790
39.

Small-cell lung cancer in England: trends in survival and chemotherapy using the National Lung Cancer Audit.

Khakwani A, Rich AL, Tata LJ, Powell HA, Stanley RA, Baldwin DR, Hubbard RB.

PLoS One. 2014 Feb 21;9(2):e89426. doi: 10.1371/journal.pone.0089426. eCollection 2014.

40.

Signalling paediatric side effects using an ensemble of simple study designs.

Reps JM, Garibaldi JM, Aickelin U, Soria D, Gibson JE, Hubbard RB.

Drug Saf. 2014 Mar;37(3):163-70. doi: 10.1007/s40264-014-0137-z.

PMID:
24550103
41.

Risk factors and survival outcome for non-elective referral in non-small cell lung cancer patients--analysis based on the National Lung Cancer Audit.

Beckett P, Tata LJ, Hubbard RB.

Lung Cancer. 2014 Mar;83(3):396-400. doi: 10.1016/j.lungcan.2013.10.010. Epub 2013 Nov 8.

PMID:
24457105
42.

Treatment decisions and survival for people with small-cell lung cancer.

Powell HA, Tata LJ, Baldwin DR, Potter VA, Stanley RA, Khakwani A, Hubbard RB.

Br J Cancer. 2014 Feb 18;110(4):908-15. doi: 10.1038/bjc.2013.812. Epub 2014 Jan 7.

43.

The UK prevalence of hereditary haemorrhagic telangiectasia and its association with sex, socioeconomic status and region of residence: a population-based study.

Donaldson JW, McKeever TM, Hall IP, Hubbard RB, Fogarty AW.

Thorax. 2014 Feb;69(2):161-7. doi: 10.1136/thoraxjnl-2013-203720. Epub 2013 Nov 4.

PMID:
24188926
44.

Lung cancer survival in England: trends in non-small-cell lung cancer survival over the duration of the National Lung Cancer Audit.

Khakwani A, Rich AL, Powell HA, Tata LJ, Stanley RA, Baldwin DR, Duffy JP, Hubbard RB.

Br J Cancer. 2013 Oct 15;109(8):2058-65. doi: 10.1038/bjc.2013.572. Epub 2013 Sep 19.

45.

A novel semisupervised algorithm for rare prescription side effect discovery.

Reps JM, Garibaldi JM, Aickelin U, Soria D, Gibson JE, Hubbard RB.

IEEE J Biomed Health Inform. 2014 Mar;18(2):537-47. doi: 10.1109/JBHI.2013.2281505.

PMID:
24043412
46.

Presence of a prothrombotic state in people with idiopathic pulmonary fibrosis: a population-based case-control study.

Navaratnam V, Fogarty AW, McKeever T, Thompson N, Jenkins G, Johnson SR, Dolan G, Kumaran M, Pointon K, Hubbard RB.

Thorax. 2014 Mar;69(3):207-15. doi: 10.1136/thoraxjnl-2013-203740. Epub 2013 Sep 3.

PMID:
24002055
47.

Early mortality after surgical resection for lung cancer: an analysis of the English National Lung cancer audit.

Powell HA, Tata LJ, Baldwin DR, Stanley RA, Khakwani A, Hubbard RB.

Thorax. 2013 Sep;68(9):826-34. doi: 10.1136/thoraxjnl-2012-203123. Epub 2013 May 17.

PMID:
23687050
48.

Chronic obstructive pulmonary disease and risk of lung cancer: the importance of smoking and timing of diagnosis.

Powell HA, Iyen-Omofoman B, Baldwin DR, Hubbard RB, Tata LJ.

J Thorac Oncol. 2013 Apr;8(4):e34-5. doi: 10.1097/JTO.0b013e31828950e3. No abstract available.

49.

Using socio-demographic and early clinical features in general practice to identify people with lung cancer earlier.

Iyen-Omofoman B, Tata LJ, Baldwin DR, Smith CJ, Hubbard RB.

Thorax. 2013 May;68(5):451-9. doi: 10.1136/thoraxjnl-2012-202348. Epub 2013 Jan 15.

PMID:
23321602
50.

The pathological confirmation rate of lung cancer in England using the NLCA database.

Khakwani A, Rich AL, Tata LJ, Powell HA, Stanley RA, Baldwin DR, Hubbard RB.

Lung Cancer. 2013 Feb;79(2):125-31. doi: 10.1016/j.lungcan.2012.11.005. Epub 2012 Dec 4.

PMID:
23218790

Supplemental Content

Loading ...
Support Center